Ruimin Hu
Chongqing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Decoding Undesirable Inflammatory Responses of Nucleic Acid-Delivering Lipid Nanoparticles.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 19, 2026
Modulation of the intestinal microbiome and reversal of the immunosuppressive microenvironment by nanoparticles for chemoimmunotherapy in prostate cancer.
Journal: Journal of advanced research
Published: October 08, 2025
The CTSZ-TRA2A-IL32 axis defines a targetable macrophage-dependent pathway in metastatic prostate cancer.
Journal: Journal of translational medicine
Published: April 15, 2025
Epithelial cells derived exosomal miR-203a-3p facilitates stromal inflammation of type IIIA chronic prostatitis/chronic pelvic pain syndrome by targeting DUSP5 and increasing MCP-1 generation.
Journal: Journal of nanobiotechnology
Published: November 19, 2023
Nanotherapeutics for prostate cancer treatment: A comprehensive review.
Journal: Biomaterials
Published: September 27, 2023
Phytic acid-modified manganese dioxide nanoparticles oligomer for magnetic resonance imaging and targeting therapy of osteosarcoma.
Journal: Drug delivery
Published: March 01, 2023
Glucocorticoid nanoformulations relieve chronic pelvic pain syndrome and may alleviate depression in mice.
Journal: Journal of nanobiotechnology
Published: December 29, 2022
In vivo targeting capacities of different nanoparticles to prostate tissues based on a mouse model of chronic bacterial prostatitis.
Journal: Frontiers in bioengineering and biotechnology
Published: August 17, 2022
Antibiotic-loaded reactive oxygen species-responsive nanomedicine for effective management of chronic bacterial prostatitis.
Journal: Acta biomaterialia
Published: December 27, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026